autoimmune disease
Pfizer and Roivant launch autoimmune specialist Priovant
Phil Taylor
autoimmune disease, partnering, Pfizer, Priovant, Roivant
0 Comment
AbbVie and Cugene partner to tackle autoimmune diseases
Joy Persaud
AbbVie, autoimmune disease, immunology, pharma, R&D, Rinvoq
0 Comment
3rd B & T Cell-Mediated Autoimmune Disease Drug Development Summit
Jessica Durston
autoimmune, autoimmune disease, b cells, R&D, T-cells
0 Comment
Industry-led forum focused on B & T Cell Collaboration
UCB chases after Argenx with FcRN drug for myasthenia gravis
Phil Taylor
Argenx, autoimmune disease, efgartigimod, myasthenia gravis, rozanolixizumab, UCB
0 Comment
Flash FDA approval sends ChemoCentryx spiralling upwards
Phil Taylor
autoimmune disease, avacopan, ChemoCentryx, fda, rare disease, regulatory approval, Tavneos
0 Comment
Lilly has a bad hair day as Pfizer rival hits the mark in alopecia
Phil Taylor
alopecia, autoimmune disease, Concert Pharma, Eli Lilly, Incyte, JAK inhibitor, Pfizer
0 Comment
FDA sets September review date for Calliditas’ rare kidney disease drug
Phil Taylor
autoimmune disease, Calliditas, fda, IGaN, kidney disease, nephrology, rare disease
0 Comment
Calliditas eyes 2022 approval in EU for rare kidney disease drug Nefecon
Phil Taylor
autoimmune disease, Calliditas, ema, kidney disease, nephrology, rare disease
0 Comment